Apply for Funding

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more about the grants process.

Recruitment of First-Time, Tenure-Track Faculty Members

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research.

 

Award: Up to $2 million over a 5-year period

Review Cycle  Fiscal Year 2024 - Cycle 12

RFA Release   May 15, 2024

Application Receipt    June 20, 2024

Application Review    July 2024

Award Notification     August 2024

 

Review Cycle Fiscal Year 2024 - Cycle 1
RFA Release May 15, 2024
Application Receipt May 15, 2024 - June 20, 2024
Application Review July 2024
Award Notification August 2024

Collaborative Action Program (CAP) to Reduce Liver Cancer Mortality in Texas: Collaborative Action Center (Competitive Renewal)

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports a competitive renewal of one single Collaborative Action Center whose function will be to innovatively expand the administrative services, resources, and support to CPRIT funded hepatocellular cancer research projects.

 

Award: Up to $3,000,000 in total costs for a period of 5 years

Review Cycle Fiscal Year 2025 - Cycle 1
RFA Release February 22, 2024
Application Receipt March 19, 2024 - June 11, 2024
Application Review June 2024 - February 2025
Award Notification February 2025

Individual Investigator Research Awards for Early-Onset Cancers

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports innovative research projects that will significantly advance the knowledge of the etiology, prevention, cancer biology, and treatment of early-onset cancers.   

Award: Up to $300,000 per year for a 3-year period

Review Cycle Fiscal Year 2025 - Cycle 1
RFA Release February 22, 2024
Application Receipt March 19, 2024 - June 11, 2024
Application Review June 2024 - February 2025
Award Notification February 2025

Individual Investigator Research Awards for Clinical Trials

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications that propose innovative cancer clinical studies in adults or children and adolescents that are hypothesis driven and involve patients enrolled prospectively on a clinical trial. Areas of interest include clinical studies of new or repurposed drugs, hormonal therapies, immune therapies, surgery, radiation therapy, stem cell transplantation, combinations of interventions, or therapeutic devices. Clinical trial must be planned to begin when contract is awarded.

 

Award: Up to $400,000 per year for a period of up to 4 years

Review Cycle Fiscal Year 2025 - Cycle 1
RFA Release February 22, 2024
Application Receipt March 19, 2024 - June 11, 2024
Application Review June 2024 - February 2025
Award Notification February 2025

Individual Investigator Research Awards for Prevention and Early Detection

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications which propose clinical and population-based projects designed to develop effective prevention and early detection interventions to reduce cancer risk, mortality, and morbidity among Texans. Projects that propose such research collaborations with existing CPRIT Prevention Program awardees including the CPRIT funded Texas Collaborative Center for Hepatocellular Cancer (https://www.bcm.edu/research/labs-and-centers/research-centers/texas-collaborative-center-for-hepatocellular-cancer) are strongly encouraged.

Award: Up to $300,000 per year for a period of up to 4 years

Review Cycle Fiscal Year 2025 - Cycle 1
RFA Release February 22, 2024
Application Receipt March 19, 2024 - June 11, 2024
Application Review June 2024 - February 2025
Award Notification February 2025

Individual Investigator Research Awards for Cancer in Children and Adolescents

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, progression, detection, or treatment of cancer in children and adolescents. Laboratory, clinical, or population-based studies are all acceptable. CPRIT expects the outcome of the research to reduce the incidence, morbidity, or mortality from cancer in children and/or adolescents in the near- or long-term. 

Award: Up to $300,000 per year for a period of up to 4 years

Review Cycle Fiscal Year 2025 - Cycle 1
RFA Release February 22, 2024
Application Receipt March 19, 2024 - June 11, 2024
Application Review June 2024 - February 2025
Award Notification February 2025

Individual Investigator Research Awards for Computational and Systems Biology of Cancer

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative mathematical and/or computational research projects addressing questions that will advance current knowledge in the (a) mechanisms that tie altered gene expression and downstream molecular mechanisms to functional cancer phenotypes and/or (b) mechanisms that tie tumor morphology to functional cancer phenotypes and/or mechanisms that tie treatment sequence and combination to evolving functional cancer phenotypes (that emerge as a result of treatment selection).

 

Award: Up to $350,000 per year for a period of up to 3 years

Review Cycle Fiscal Year 2025 - Cycle 1
RFA Release February 22, 2024
Application Receipt March 19, 2024 - June 11, 2024
Application Review June 2024 - February 2025
Award Notification February 2025

Individual Investigator Research Awards

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. Areas of interest include laboratory research, translational studies, and/or clinical investigations.

 

Award: Up to $300,000 per year for a 3-year period

Review Cycle Fiscal Year 2025 - Cycle 1
RFA Release February 22, 2024
Application Receipt March 19, 2024 - June 11, 2024
Application Review June 2024 - February 2025
Award Notification February 2025

Cancer Screening and Early Detection

Revised: 03/07/2024

Instructions for Applicants
Revised: 03/07/2024

Program Prevention
RFA Status Open
Description

This award mechanism seeks to support the delivery of evidence-based clinical services to screen for cancer and pre-cancer in underserved populations who do not have adequate access to cancer early detection interventions and health care, bringing together networks of public health and community partners to carry out programs tailored for their communities. Projects should identify cancers that cause the most burden in the community, have nationally recommended screening methods, and use evidence-based methods to screen for these cancers.

Award: Maximum of $1M for new projects and $2.5M for expansion projects

Duration: Maximum 5 years

Review Cycle Fiscal Year 2025 - Cycle 1
RFA Release February 09, 2024
Application Receipt March 07, 2024 - June 06, 2024
Application Review June 2024 - September 2024
Award Notification November 2024

Dissemination of CPRIT-Funded Cancer Control Interventions

Revised: 03/07/2024

Instructions for Applicants
Revised: 03/07/2024

Program Prevention
RFA Status Open
Description

This award mechanism seeks to fund projects that will facilitate the dissemination and implementation of successful CPRIT Prevent Program-funded, evidence-based cancer prevention and control interventions across Texas. The proposed project should be able to develop one or more "products" based on the results of a previously CPRIT Prevention Program-funded intervention project. The proposed project should describe and package strategies or approaches for dissemination to other partners, settings, and populations in the state.


Award: Maximum of $450,000

Maximum duration of 3 years 

Review Cycle Fiscal Year 2025 - Cycle 1
RFA Release February 09, 2024
Application Receipt March 07, 2024 - June 06, 2024
Application Review June 2024 - September 2024
Award Notification November 2024

Primary Prevention of Cancer

Revised: 03/07/2024

Instructions for Applicants
Revised: 03/07/2024

Program Prevention
RFA Status Open
Description

This award mechanism focuses on increasing implementation of evidence-based strategies to ensure that all Texans benefit from the cancer prevention knowledge that we currently have. CPRIT seeks to fund multilevel interventions to reduce cancer risk, disease burden, and cancer disparities. Modifiable risk behaviors include tobacco use, obesity, physical inactivity, unhealthy eating, alcohol use, sun exposure, HPV vaccination, Hepatitis B vaccination, and environmental/ occupational cancer exposures. Applications should also assess and address social determinants that contribute to cancer burden and disparities (e.g., cultural factors, unmet needs, access barriers). Interventions and communications should be structured to address the unique circumstances of the population to be served. 


Award: Maximum of $1M for new projects and $2.5M for expansion projects

Duration: Maximum 5 years 

Review Cycle Fiscal Year 2025 - Cycle 1
RFA Release February 09, 2024
Application Receipt March 07, 2024 - June 06, 2024
Application Review June 2024 - September 2024
Award Notification November 2024